CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TheraPanacea aims to enhance radiotherapy treatment planning through a digital, patient-specific system. The project focuses on improving treatment quality, reducing side effects, and increasing the efficiency of device usage to benefit more patients undergoing cancer treatment.
TheraPanacea seeks to provide digital, innovative, patient-specific, and adaptive radiotherapy treatment planning system.
Our objectives are the following: (i) improve the quality of treatment towards increasing the survival rate, while (ii) reducing the side effects towards diminishing the disastrous long term radiation impact and (iii) improving the efficiency of device use towards increasing significantly the number of patients being treated.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
